Manipulating levels of uncertainty in a decision making task for obsessive-compulsive disorder
The study aims to investigate whether manipulating levels of uncertainty would influence performance in a decision-making task in obsessive-compulsive disorder (OCD).
Seeking psychiatric emergency care by individuals who died by suicide in Fortaleza in 2022
Suicide represents 1% of all deaths in the world. It's more prevalent in underdeveloped countries. Suicide mortality in Brazil has been growing in recent years. We Evaluated whether patients who committed suicide in Fortaleza sought the only psychiatric emergency service in the State before the act during the year 2022.
Virtual reality, social intelligence, mirror neurons and bipolar spectrum a new perspective
Satisfactory Levels of Functionality and Quality of Life in Caregivers of Patients with Bipolar Disorder: Is this Possible?
To measure the levels of functionality and QoL of caregivers of patients with BD, investigating the association between them, as well as the relationship with clinical and sociodemographic data of these caregivers.
Adventures of Psychiatry in a General Hospital: A tale of C-L psychiatry origins and resistance in Brazil
Costs of dementia in Brazil
Given the increasing number of people with dementia in Brazil, there is an urgency for health and social systems to plan strategies to meet the needs of this population and their families. Therefore, research on dementia costs is essential. This study estimated direct and indirect costs related to dementia in Brazil.
A rare event of late agranulocytosis during clozapine use in schizophrenia and the importance of monitoring vitamin B12 levels in patients with severe psychiatric conditions: a case report
Signal Mining and Risk Analysis of Olanzapine Adverse Events in the FAERS Database
This study aims to assess the safety profile of Olanzapine by analyzing adverse events (AEs) reported in the FAERS database, particularly focusing on newly identified risks.
Brazilian Psychiatric Association guidelines for the treatment of Social Anxiety Disorder
Social anxiety disorder (SAD) is one of the most prevalent anxiety disorders, often not well recognized. In most of the cases, SAD follows an unremitted and chronic course, affecting several areas of the individual functioning (i.e.: relationship, academic, work). Due to its relevance, there is a need for guideline-based treatments for SAD treatment adapted to the Brazilian social and economic reality.
A randomized, double-blind, placebo-controlled trial of N-acetylcysteine as an adjuvant treatment for alcohol use disorder
We aimed to assess the effect of N-acetylcysteine (NAC), as an adjuvant treatment, on treatment adherence (primary outcome), in peripheral biomarkers and clinical improvement (secondary outcomes) in alcohol use disorders (AUD) patients.
Maternal depressive symptoms trajectories and harsh parenting: the mediating role of maternal quality of life in the 2004 Pelotas Birth Cohort
To study the impacts of maternal depressive symptoms trajectories and harsh parenting and explore if the maternal quality of life mediates this association.
Risk of Suicide in Association with Major Depressive Disorder among Patients with Dementia: A Population-based Nested Case-Control Study
This study aimed to explore the association between major depressive disorder (MDD) and suicide risk in dementia patients.
Moral Harassment and Mental Health in Medical Residents: A Longitudinal Study
This study investigates if moral harassment contributes to anxiety, depression and burnout among medical residents.
Brazil has a problem: Where is the research about eating disorders in Brazil?
Risks of Hyperopia, Myopia, Astigmatism, and Strabismus in Children With Autism Spectrum Disorder: A Nationwide, Population-Based Cohort Study
In this population-based cohort study, we compared the risks of incident hyperopia, myopia, astigmatism, and strabismus between children with autism spectrum disorder (ASD) and children without ASD.
Trajectories of anxiety, depression, and posttraumatic stress among healthcare workers during the COVID-19 pandemic: one-year monthly follow-up
This study aimed to assess longitudinal patterns of anxiety, depression, and posttraumatic stress symptoms, as well as their predictors, in a reference hospital workforce during the first two waves of the pandemic in Brazil.
Mental health predictors of Internet Gaming Disorder: a longitudinal study
We aim to evaluate whether a wide range of baseline mental disorders predict Internet Gaming Disorder (IGD) one to three years later, among university students.
Floods in southern Brazil: the urgent need for mental health support in the context of climatic disasters
The amygdala as a therapeutic target for aggressive and disruptive behaviors: Systematic review
To identify the effects of amygdala neuromodulation in the management disruptive behavior in patients, as well as changes in their quality of life and its relationship with epilepsy.
Longitudinal Gut Microbiota Composition During Perinatal period in Women with Different Intensities of Depressive Symptoms
Depressive symptoms during perinatal significantly impact mothers and infants. Emerging evidence suggests a connection between gut microbiota and mood regulation. This study investigated whether depressive symptoms are associated with changes in the gut microbiota of women during the perinatal period.
Predictors of response to emotional distress with Single session interventions: using Enhanced Psychoeducation in a crisis situation
Single-session interventions (SSI) are an effective strategy reducing emotional distress. Enhanced psychoeducation (EP), which includes empathic listening, risk stratification, symptom monitoring, and habit modification is particularly suitable for SSIs. We investigate predictors of response to an online EP intervention among essential service professionals during COVID-19 in Brazil. TELEPSI Project financed by the Ministry of Health of Brazil, nationwide initiative, which served more than 3,300 individuals in various psychotherapeutic modalities. Data from April 2020 to December 2021. We included all participants who received SSIs with high levels of emotional distress. Final sample: 460 subjects, 89.1% female, and 81.1% health professionals. 300 subjects underwent reassessment in one month. Participants with harmful use of social networks, spending time on social media, playing video games, smoking, drinking alcohol, spending time with pets had a less pronounced symptom decrease. Participants who played instruments or already received some psychological treatment showed a greater magnitude of symptom decrease. This highlighted the impact of lifestyle factors on the efficacy of SSIs. These results underscore the importance of considering individual lifestyle factors when implementing SSIs and contribute to growing body of evidence supporting the tailored application of psychoeducational strategies in mental health interventions, particularly in high-stress environments.
Parenthood and All-cause Mortality in Older Adults with Schizophrenia: A Multicenter 5-Year Prospective Study
The large body of literature examining the association between parenthood and mortality in the general population contrasts with a lack of studies among older adults with schizophrenia. Identifying potential protective factors of premature death in this population is important to help guide prevention measures. Here, we examined whether all-cause and cause-specific mortality rates significantly differ between older adults with schizophrenia with and without children, during a 5-year follow-up.
Introducing a New Severity Specifier for Schizophrenia: Conceptual Framework and Clinical Implications
Schizophrenia patients represent a heterogeneous group in clinical presentation and severity. Although severity has been operationalized in different ways, mostly on a gradient between symptom severity and functional impairment, such approaches are limited in capturing real-world functioning. We suggest adopting the severity model proposed by DSM-5 for autism spectrum disorders. The model defines three levels of severity, based on the support required, directly addressing two barriers from previous models: real-world functioning and ease of implementation. Our adapted model includes three new features: First, this severity specifier is global, rather than for each symptom domain. Second, the centrality of occupational functioning is emphasized to define the level of support. Third, we propose a one-month timeframe for severity appraisal, standardizing the assessment process. Considering practical utility, we indicate how severity assessment can guide clinical practice towards rehabilitation. Additionally, we outlined operational definitions for severity and functioning in schizophrenia, aligned with the premises of our model. Finally, we acknowledge potential limitations, the most relevant being the need for empirical validation. The model is presented to foster discussion. Additional studies will follow to investigate inter-rater reliability and convergent validation with standard measures of symptom and functioning severity.
Narrative therapy online intervention improves post-traumatic stress disorder symptoms, perceived stress, anxiety, and depression in nurses: A randomized controlled trial
Clinical nurses have symptoms of post-traumatic stress disorder (PTSD), anxiety and depression, which seriously affect their physical and mental health. Narrative therapy (NT), a therapy for trauma-related psychological disorders, may be an effective intervention.
Download to Heal: Navigating the Pixelated Path of Digital Therapeutics in Psychiatric Care
Digital therapeutics have evolved rapidly with technological advances in healthcare. Despite their increasing use, gaps remain in understanding their regulatory frameworks, integration, and efficacy for conditions like substance use disorder, insomnia, attention deficit hyperactivity disorder, and post-traumatic stress disorder. This study evaluates FDA-approved digital therapeutics and explores their potential to revolutionize psychiatric treatments amid ongoing technological and regulatory changes. We conducted a comprehensive review of major databases, focusing on articles published up to January 2024 on FDA-approved digital therapeutics. We excluded non-English articles and those lacking empirical data or focusing on non-FDA-approved therapeutics. Our analysis covered regulatory compliance, clinical outcomes, and integration with traditional treatments. The review of nine FDA-cleared digital therapeutics revealed benefits like improved treatment accessibility and potential reductions in healthcare costs. For example, Somryst, a cognitive-behavioral therapy-based treatment for insomnia, showed that over 40 percent of users overcame chronic insomnia, and 60 percent experienced improvements without adverse effects. However, challenges remain, including low provider adoption, inadequate insurance coverage, and high user dropout rates. While digital therapeutics enhance accessibility, they face regulatory challenges, reimbursement issues, and the need for robust clinical evidence. Success depends on collaboration among stakeholders to demonstrate value, ensure safety, and integrate them into existing healthcare systems.
Effect of home-based transcranial direct current stimulation combined with nutritional counseling therapy on binge eating disorder symptoms: A randomized pilot trial
To examine the effect of nutritional counseling therapy (NCT) combined with transcranial direct current stimulation (tDCS) on Binge Eating Disorder (BED) symptoms.
Addressing the elephant in the screening room: an item response theory analysis of the Prodromal Questionnaire (PQ-16) for at-risk symptoms of psychosis
Within the context of patients at-risk of psychosis, where a variety of symptoms are present, identifying the most discriminative symptoms is essential for efficient detection and management.
Association between Depressive Symptoms and Social Support in a Nationally Representative Sample Of Older Adults (ELSI-Brazil)
To investigate the association between depressive symptoms and social support among a representative sample of the Brazilian population aged 50 years or older.